Tosuner, Z. Et Al. 2017. The Role of EGFR, Hepatocyte Growth Factor Receptor (c-Met), c-ErbB2 (HER2-neu) and Clinicopathological Parameters in the Pathogenesis and Prognosis of Chordoma. TURKISH JOURNAL OF PATHOLOGY , vol.33, no.2 , 112-120.

Tosuner, Z., Bozkurt, S. U., KILIÇ, T., & Yilmaz, B., (2017). The Role of EGFR, Hepatocyte Growth Factor Receptor (c-Met), c-ErbB2 (HER2-neu) and Clinicopathological Parameters in the Pathogenesis and Prognosis of Chordoma. TURKISH JOURNAL OF PATHOLOGY , vol.33, no.2, 112-120.

Tosuner, Zeynep Et Al. "The Role of EGFR, Hepatocyte Growth Factor Receptor (c-Met), c-ErbB2 (HER2-neu) and Clinicopathological Parameters in the Pathogenesis and Prognosis of Chordoma," TURKISH JOURNAL OF PATHOLOGY , vol.33, no.2, 112-120, 2017

Tosuner, Zeynep Et Al. "The Role of EGFR, Hepatocyte Growth Factor Receptor (c-Met), c-ErbB2 (HER2-neu) and Clinicopathological Parameters in the Pathogenesis and Prognosis of Chordoma." TURKISH JOURNAL OF PATHOLOGY , vol.33, no.2, pp.112-120, 2017

Tosuner, Z. Et Al. (2017) . "The Role of EGFR, Hepatocyte Growth Factor Receptor (c-Met), c-ErbB2 (HER2-neu) and Clinicopathological Parameters in the Pathogenesis and Prognosis of Chordoma." TURKISH JOURNAL OF PATHOLOGY , vol.33, no.2, pp.112-120.

@article{article, author={Zeynep Tosuner Et Al. }, title={The Role of EGFR, Hepatocyte Growth Factor Receptor (c-Met), c-ErbB2 (HER2-neu) and Clinicopathological Parameters in the Pathogenesis and Prognosis of Chordoma}, journal={TURKISH JOURNAL OF PATHOLOGY}, year=2017, pages={112-120} }